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Abstract 
 
The objective of this article is to assess the impact of the smoke-free legislation implemented 
from 2007 on emergency hospital admissions among patients with chronic obstructive 
pulmonary disease (COPD) in England. A time series design involving routinely collected hospital 
episode statistics data was employed. Ecological analyses were conducted using Poisson 
regression to evaluate whether annual emergency admissions among COPD patients changed 
following the introduction of the UK smoking-ban legislation in 2007. The analysis was based on 
aggregated hospital episodes statistics (HES) data for the financial years 2002/03 to 2011/2012, 
representing the five-year periods before and after the legislation. Setting England. All patients 
aged 40 or older with an emergency admission coded with a diagnosis of COPD. Main outcome 
measures Annual number of completed emergency hospital admissions. The pattern of 
emergency admissions for COPD differed between men and women in the periods before and 
after the introduction of the smoking ban legislation. After adjusting for variation in population 
size, age and population smoking prevalence, a statistically significant reduction in emergency 
admissions among men in the years after the ban was observed when compared with the 
corresponding period prior to the ban- having declined by 9% (95% CI: 7% - 12%; P< 0.01). In 
contrast, levels remained unchanged for women over the study period. Emergency admissions 
for COPD remained unchanged in women but declined among men by as much as 9% in the five 
years after the introduction of smoke-free legislation in England. 
 
Keywords: COPD, Hospital Episodes Statistics, Ecological Analysis, Smoking Ban. 
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Introduction 
 
As defined in GOLD 2014 by Vestbo et al 
(2014), which is an update of GOLD 2001 by 
Pauwels et al (2001), chronic obstructive 
pulmonary disease (COPD) is a common 
preventable and treatable disease 
characterized by airflow limitation that is 
usually progressive and is also associated 
with an enhanced chronic inflammatory 
response in the airways and the lung to 
noxious particles or gases. According to the 
joint guidelines by Celli et al (2004) on 
behalf of the American Thoracic Society and 
the European Respiratory Society (ATS-
ERS), COPD is characterized by airflow 
limitation that is not fully reversible. Indeed, 
according to the WHO (2012), it is one of the 
fastest growing diseases in the world, 
affecting the lives of 210 million people and 
contributing to 5% of deaths globally. 
Fletcher et al (1976) and Antó et al (2001) 
both reported the disease as often left 
undiagnosed for many years, particularly in 
its early stages. Its progression has been 
described by Mannino and Kiri (2006) as 
varying by phenotype- a concept that 
remains poorly understood. According to 
NICE (2010), evidence suggests an 
estimated three million people are affected 
by COPD in the UK with only about 900,000 
having been diagnosed. 
 
COPD exacerbation is a major cause of 
hospitalization. According to a report by 
LAIA: the Lung and Asthma Information 
Agency (2001), figures for the period 1995-
2004 in the UK indicate a 50% increase in 
COPD exacerbations- responsible for many 
emergency hospital admissions over the 
period. The WHO (2004) reported the 
disease as accounting for over 108,000 
emergency admissions in, for example, the 
financial year 2004/2005 and projected that 
it would rise to almost 160,000 admissions 
by 2028- costing an estimated £376 million 
annually. Indeed, the importance of COPD to 
the UK public health is highlighted by its 
inclusion among the nine target health 
conditions for which there have been since 
2005, National Service Frameworks (NSFs) 
and strategies for qualitative care by the 
Department of Health (2005). 
 
Although occupational exposure to dusts 
and chemicals as well as the genetic 
disorder known as alpha-1-antitrypsin 
deficiency are known to increase the risk of 
COPD, GOLD 2001 by Pauwels et al (2001) 
have identified cigarette smoking as by far 
the most important risk factor for the 
disease. According to the National Heart, 
Lung and Blood Institute (2012), there is 
also emerging evidence a patient can 
develop COPD if they live with a smoker or 
breathe in second-hand smoke routinely 
elsewhere. In general, according to reports 
by the American Thoracic Society (1995), 
Pauwels et al (2001) in GOLD 2001 and 
Vestbo et al (2014) in GOLD 2014, apart 
from the harm caused by exposure to 
tobacco smoke, such COPD patients will lose 
lung function more quickly than those who 
are not exposed as the smoke destroys the 
tiny hair-like cilia that normally repair and 
clean the airways. According to the WHO 
(2014), regular exposure to second-hand 
smoke can increase a person’s risk of heart 
disease and lung cancer by as much as a 
third as well as make it more likely to 
develop COPD. Indeed, studies by Dayal et al 
(1994), Leuenberger et al (1994), Berglund 
et al (1999) and Larsson et al (2003)- to list 
but four, suggest there is mounting evidence 
COPD might be independently associated 
with passive smoking. Other reports by the 
U.S. Department of Health and Human 
Services (2006), Eisner (2009) and Jordan 
et al (2011) also suggested second hand 
smoking might be associated with poorer 
health status and a greater risk of COPD 
exacerbation. According to NICE (2010), 
COPD exacerbation is a major driver of 
emergency admissions for COPD in the UK.  
Indeed, Jordan et al (2001) and Mannino 
and Buist (2007) have separately suggested 
passive smoking as strongly implicated in 
the etiology of COPD. A study by the UK 
Royal College of Physicians (2005) and 
another by Sims et al (2010) both reported 
smoke exposure levels as having been 
declining since the mid-1990s in England 
such that the levels among non-smoking 
adults living with non-smoking partners in 
2003 were about half the levels in 1993.  
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Since July 2007, there has been smoking ban 
in England at enclosed places of work as 
well as enclosed places which are open to 
the public, such as where goods and services 
can be obtained, including private clubs and 
certain other designated places as described 
in chapter one of the Health Act of 2006, the 
details of which can be found in the National 
Archives (2006). The term “smoking ban” 
was used interchangeably with smoke-free 
legislation in this study. The ban in England 
followed from similar bans introduced 
earlier in Scotland (March 2006), Wales and 
Northern Ireland (April 2007) and amidst 
evidence about the benefits of such bans to 
the health of the population, especially with 
regard to the risk of myocardial infarction 
(MI) as reported by Bartecchi et al (2006) 
and Khuder et al (2007). However, to date 
the benefits of the smoking ban legislation 
specifically for COPD have not been 
investigated yet. It is reasonable to expect 
the smoking legislation to offer similar 
benefits to COPD patients in terms of 
reductions in emergency admissions.  
 
In terms of risks associated with exposure 
to passive smoking, the impact on COPD 
(especially its exacerbation) is widely 
recognized and according to Eisner (2009) , 
Mannino and Buist (2007) and Eisner et al 
(2009), COPD patients are likely to benefit 
the most from declining exposure to passive 
as well as active smoking than those 
without COPD. Two recent UK studies by 
Sims et al (2010) and Mackay et al (2010)- 
both of which are based on routinely 
collected hospital admission data have 
reported benefits of the ban in the form of 
reductions in emergency admission rates 
for MI in England and asthma in Scotland 
respectively. It was thus reasonable to 
assess whether similar benefits could be 
found for COPD using the same database. 
We know from Holguin et al (2005), 
Anecchino et al (2007) and Boutin-Forzano 
et al (2007) that the overwhelming majority 
of COPD patients also suffer from other 
diseases as comorbidities are associated 
with a number of the poorer outcomes 
experienced by these patients. Actually, the 
most common of these comorbidities 
include hypertension, heart failure and 
coronary artery disease- all of which are 
known to be strongly associated with the 
risk of MI. Indeed, with about 40% of COPD 
patients having heart disease as reported by 
Anecchino et al (2007) and between 17%-
42% of them also living with high blood 
pressure as reported by Boutin-Forzano et 
al (2007). 
The aim of this study was to assess whether 
there was any significant change in the 
annual number of emergency admissions 
for COPD among persons aged 40 and older 
following the implementation of the smoke-
free legislation in England.  
 
Methods 
 
Data 
 
The National Health Service (NHS) in 
England routinely collects information in 
the form of Hospital Episode Statistics (HES) 
on all patients who receive care in its 
hospitals. The HES data are freely available 
online from the website of the Health and 
Social Care Information Centre, UK (2013; 
http://www.hscic.gov.uk/) and the annual 
national aggregated data for COPD 
(classified in HES as ICD-10 J43-J44) for the 
financial years 2002/03 to 2011/2012 were 
used. In accordance with the suggestion by 
Zwar et al (2011), persons younger than 40 
years were excluded to minimize the 
possible impact of misdiagnosis of the 
disease. Only data on all emergency 
admissions are freely available with age and 
sex breakdown. Therefore, for each year and 
sex, the age distribution of finished 
consultant episodes for COPD were used as 
weights on the corresponding age 
distribution of all emergency admissions to 
derive modified weights to apply on the 
corresponding data for the total emergency 
admissions for COPD to obtain the study 
data.  
 
Corresponding mid-year population 
estimates were obtained from the Office for 
National Statistics (ONS), UK (2012). The 
chosen period represented the last five 
years prior to implementation of the 
smoking ban legislation (i.e. 2002/03 to 
2006/07 as 2002-2006) and afterwards (i.e. 
2007/08 to 2011/12 as 2007-2011). The 
annual data on cigarette smoking 
prevalence for the UK were similarly 
obtained from the ONS and were used to 
adjust for the direct effect of smoking in the 
trend analyses. To estimate the annual 
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admission rates, the mid-year population 
estimates were considered as the 
corresponding patients at risk of emergency 
admission for COPD- a common practice for 
the analysis of aggregated data as described 
by Esteve et al (1994).  
 
Statistical Analysis  
 
Poisson regression model was used to test 
the hypothesis that there was no change in 
the annual number of emergency 
admissions for COPD between the five-year 
periods before and after the ban. The annual 
number of admissions for COPD was thus 
assumed to come from a Poisson 
distribution with each admission 
considered as having occurred 
independently at random and at a constant 
rate as described by McCullagh and Nelder 
(1989) and as illustrated by Agresti (2002). 
The impact of the smoking ban was assessed 
in terms of percentage change in emergency 
admission rates for COPD between the two 
periods- calculated as the exponent of the 
estimated incident reporting ratio (IRR) 
with the corresponding 95% confidence 
interval (CI). Thus, in common with Sims et 
al (2010), the model included the 
introduction of the smoking ban as a binary 
predictor variable (= 1 for the ban period 
2007-2011 and =0 for the period 2002-
2006), sex, age and the annual smoking 
prevalence. To avoid any assumption on the 
form of relationship between annual 
smoking prevalence and the outcome, the 
variable was log-transformed in preference 
over categorization. The annual mid-year 
population estimate for England was used 
as an offset variable so as to facilitate a one-
to-one relationship between the population 
size and the number of admissions.  
Stratified analyses by sex were also 
conducted to assess the impact of the 
legislation in men and women separately.  
 
In common with most ecological analyses, 
over-dispersion was anticipated as a likely 
problem and was assessed by testing for the 
significance of the deviance goodness of fit 
of the model, and the estimated standard 
errors were adjusted for its effect as 
described and illustrated by Cook and 
Weisberg (1982). The deviance (likelihood 
ratio) test statistic G² was used to assess the 
goodness-of-fit of the model. 
All analyses were done using the statistical 
software package StatsDirect version 
2.8.040. 
Sensitivity Analysis  
 
To assess whether emergency admission 
rates for COPD had been declining over time 
independently of the smoking ban, 
sensitivity analysis was conducted by 
refitting the final model separately with 
assumed false starting year of 2004 (i.e. 
three years prior to the actual) in one 
analysis and 2009 (i.e. two years after) in 
another.  
 
Two additional sensitivity analyses were 
conducted: (1) the Poisson regression 
methodology was applied to the HES data 
for myocardial infarction (MI) among 
persons aged 20 and older to replicate the 
findings of the earlier study by Sims et al 
(2010) which was based on a similar age 
group and (2) the association between the 
introduction of the smoking ban was 
investigated in relation to fractures of skull 
and facial bones among persons aged 40 
and older which was a priori assumed to 
have no direct causal link to the smoking 
ban.  
 
Results 
 
The age distribution of all emergency 
admissions in HES did not vary significantly 
from year to year according to the data for 
the financial years 2007/08 to 2011/12 as 
shown in Table 1- suggesting the 
assumption of a consistent age distribution 
over the ten-year study period was 
appropriate. The same was true for the age 
distribution of finished consultant episodes 
for COPD.  
 
There were 1,026,782 emergency 
admissions for COPD between 2002 and 
2011 which indicated a steady pattern of 
annual decline among men and women that 
started in 2005 and continued to the year of 
implementation of the smoking ban (Figure 
1). Although the annual number of 
emergency admissions for COPD was 
consistently higher in men, the sex gap had 
been on the decline since the 
implementation of the smoking ban. In the 
five-year period prior to the ban, there were 
256,340 emergency admissions for COPD 
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among men compared with 244,257 and 
women. By contrast, the corresponding 
numbers in the ban period were 260,997 
among men compared with 265188 among 
women- indicating more admissions 
occurred in women. 
 
COPD emergency admissions were 2.5% 
lower in the ban period compared to the 
period before the ban although this was not 
statistically significant (P=0.39). Emergency 
admission levels were about 30% lower in 
women when compared with the level in 
men (P< 0.0001) (Table 1).  
 
Table 1:  Estimated Incident Reporting Ratio (IRR) for COPD Emergency Admissions 
 
 
Stratified Analyses by Sex 
 
Stratified analyses showed that in men the 
number of emergency admissions for COPD 
declined significantly by 9.4% (95% CI: 
6.5% - 12.3%; P< 0.0001) during the period 
of the smoking-ban compared to the similar 
period prior to the ban. By contrast, in 
women emergency admissions were 2% 
higher in the ban period although this was 
not statistically significant (P< 0.1838). This 
implies that with respect to COPD 
emergency emissions, the introduction of 
the smoking ban has had a more 
pronounced effect in men than in women.  
 
Sensitivity Analysis in COPD 
 
In the sensitivity analysis involving 2004 as 
the starting year of the implementation of 
the smoking ban on the data for men, there 
was no evidence of a smoking-ban effect. 
Instead, there was a non-significant increase 
of 0.7% (P=0.85) in the number of 
emergency admissions for COPD in the ban  
 
period when compared with the period 
prior to 2004. When 2009 was assumed as  
 
 
the starting year of the smoking ban, the 
number of emergency admissions for COPD 
in the ban period having declined by 8.5% 
(95% CI: 5.8% - 11.1%; P< 0.0001) when 
compared with the period prior to 2009.  
 
Sensitivity Analysis in Myocardial 
Infarction 
 
There were 556,023 emergency admissions 
for myocardial infarction (MI) among 
persons aged 20 and older during the study 
period. There was evidence of decline in the 
number of emergency admissions for MI in 
the ban period when compared with the 
period prior to the ban by about 19.3% 
(95% CI: 13.8% - 24.5%; P< 0.0001).   
 
Sensitivity Analysis in Fracture of Skull 
and facial Bones 
 
There were 138,876 emergency admissions 
for fracture of skull and facial bones among 
persons aged 40 and older during the study 
period. Emergency admissions for fracture 
of skull and facial bones remained largely 
unchanged in the study period- the numbers 
in the ban period indicating a non-
significant increase of 1.6% (P= 0.5342) 
Persons Men Women
IRR 95% CI
Unscaled 
P-Value
Scaled     
P-Value IRR 95% CI
Unscaled 
P-Value
Scaled     
P-Value IRR 95% CI
Unscaled 
P-Value
Scaled     
P-Value
Sex:
     Male versus
     Female 0.70 0.66-0.75 P < 0.01 P < 0.01
Age group (year):
     40-49 versus
     50-59 0.86 0.72-1.04 P < 0.01 P = 0.10 0.82 0.76-0.89 P < 0.01 P < 0.01 0.89 0.81-0.98 P < 0.01 P = 0.02
     60-69 4.59 3.25-6.47 P < 0.01 P < 0.01 4.59 4.06-5.19 P < 0.01 P < 0.01 4.18 3.44-5.08 P < 0.01 P < 0.01
     70-79 6.19 4.38-8.74 P < 0.01 P < 0.01 6.05 5.35-6.84 P < 0.01 P < 0.01 5.69 4.69-6.92 P < 0.01 P < 0.01
     80-89 21.19 15.04-29.84 P < 0.01 P < 0.01 27.0523.95-30.56 P < 0.01 P < 0.01 14.9012.28-18.08 P < 0.01 P < 0.01
     90+ 29.47 20.74-41.89 P < 0.01 P < 0.01 39.634.82-45.11 P < 0.01 P < 0.01 21.4217.59-26.07 P < 0.01 P < 0.01
Logarithm(smoking prevalence) 1.02 0.08-13.54 P = 0.1941 P = 0.93 0.96 0.81-1.14 P = 0.05 P = 0.68 0.95 0.71-1.26 P = 0.04 P = 0.70
Smoking ban legislation: 
     Before versus
     After 0.97 0.91-1.04 P < 0.01 P = 0.39 0.91 0.88-0.93 P < 0.01 P < 0.01 1.02 0.99-1.06 P < 0.01 P = 0.18
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when compared with the period prior to the 
ban.  
 
Discussions  
 
This study aimed to assess the impact of the 
smoke-free legislation since its introduction 
on emergency hospital admissions among 
patients with COPD in England as at the end 
of the financial year 2011/12.  The Hospital 
Episodes Statistics (HES) data which were 
freely available were used to compare the 
emergency admission rates for COPD 
between the five-year periods before and 
after the ban- thus adopting a similar 
approach to the two earlier HES-based UK 
studies by Sims et al (2010) and Mackay et 
al (2010).  
 
The results indicate that the frequency of 
emergency hospital admissions for COPD 
had dropped significantly only in men in the 
five-year period 2007-2011 of the smoking 
ban legislation when compared with the 
corresponding five-year period 2002-2006 
in England. In men, emergency hospital 
admissions for COPD declined by about 9% 
in the smoking ban period where as, levels 
increased by a non-significant 2% in 
women. These results indicate a narrowing 
of the sex gap. Indeed, whereas the total 
number of emergency admissions for COPD 
in the five-year period prior to the ban was 
higher in men (256,340 in men compared 
with 244,257 in women), the total for the 
succeeding five-year period was higher 
among women (260,997 in men compared 
with 265,188 in women), although the 
annual rates remained higher among men.  
 
Evidence of similar sex difference in the 
impact of the smoking ban has been 
reported for myocardial infarction by 
Cesaroni et al (2008), Vasselli et al (2008) 
and Sims et al (2010). According to Wardle 
and Mindell (2008), the reduction in women 
might be more gradual because exposure to 
second-hand smoking had declined many 
years earlier than the legislation. Of course, 
it would be prudent to treat these findings 
with due caution. 
 
Nonetheless, the sensitivity analyses 
support the finding that the introduction of 
the smoking ban, at least to some degree, 
will have contributed to the reduction in 
emergency hospital admissions in men. No 
effect was observed when 2004 was used 
instead of 2007 as the year of introduction 
and a reduced effect was found when 2009 
was used. The reduced effect for 2009 could 
be because of the overlap between the two 
periods being compared as regards the 
actual smoking ban duration. Indeed, it 
might be reasonable to expect the impact of 
the ban to have started much earlier than 
the actual year of implementation of the 
legislation- particularly since Scotland had 
implemented the ban in 2006 which could 
have possibly resulted in increased 
awareness among their fellow UK citizens 
and especially as a number of clubs, public 
bars and workplaces also introduced some 
restrictions on smoking in advance of the 
ban in 2007. Indeed, there is good reason 
why the kick-in period of any benefit of the 
legislation to COPD patients and those at 
risk of the disease might be as short as few 
weeks of its implementation since most 
emergency admissions for COPD are due to 
the exacerbations of the disease. Eisner 
(2009) has suggested COPD exacerbations 
are often triggered by exposure to irritants 
of which cigarette smoke is one. Indeed, 
Leuenberger et al (1994), Larsson et al 
(2003) and Celli et al (2004) have also 
reported that persistent exposure to 
tobacco smoke is a major cause of 
complications in COPD- most of which 
usually result in hospital admissions and 
according to Apsley and Semple (2012), 
meaningful decrease in exposure levels to 
passive smoking over a period as short as a 
few weeks could result in fewer 
exacerbations among the population at risk 
of COPD and its complications. Although the 
current study also found evidence of 
smoking ban effect for emergency hospital 
admissions on myocardial infarction, the 
magnitude of effect over the 5-year smoking 
ban period was much larger than the 2.4% 
reduction reported in the earlier UK study 
by Sims et al (2010) which was based on a 
much shorter duration. However the 
current results are within the range of levels 
reported in the US-based studies reported 
by Sargent et al (2004), Bartecchi et al 
(2006) and Khuder et al (2007)- all of which 
similarly involved long smoking ban 
durations. Furthermore, the absence of 
smoking ban effect on emergency hospital 
admissions for fracture of skull and facial 
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bones is in line with expectation for a 
condition generally recognized as unrelated 
to smoking. Together, these imply that the 
effects found are likely not artefacts of the 
data and methodology used, and the 
observed effects can, at least to some extent, 
be attributed to the introduction of the ban. 
 
Although extensive literature review would 
suggest no other major nationwide public 
health policy was introduced in England 
during the period of the smoking legislation 
which could account for the effect found for 
the ban, there might be, however, several 
possible other reasons that could explain, or 
may contribute to these findings. It is 
reasonable to expect COPD patients and 
indeed persons who are susceptible to 
smoking induced COPD to also benefit from 
the reduced levels of emergency admissions 
for myocardial infarction widely reported as 
resulting from the smoking ban since the 
condition is a known major risk factor for 
COPD. It is also reasonable to expect 
improvements in the management of the 
disease, most notably changes in the use of 
more effective drugs against COPD 
exacerbations over the study period as 
reported by Soriano et al (2002 and 2003) 
and also by Kiri et al (2005a and 2005b) as 
also likely to account for the reduction in 
emergency admissions for COPD.   
 
Limitations  
 
The current analyses were based on the 
following assumptions: that (1) the sex 
distribution of emergency admissions for 
COPD was similar to the corresponding 
distribution for all finished consultant 
episodes for COPD, (2) the age distribution 
of emergency admissions for COPD was 
similar to the distribution for all emergency 
admissions and (3) the age distribution was 
stable over the 10-year study period in each 
sex. Thus, the validity of the study findings 
might depend on the validity of these 
assumptions. According to data from the 
Public Health Intelligence Team of NHS 
Hounslow (2012), the assumptions might be 
reasonable.  
 
A major limitation of the study was the 
unavailability of patient-level data, rich 
enough to include information on the key 
risk factors of COPD. Although the previous 
UK studies by Sims et al (2010) and Mackay 
et al (2010) also used aggregated HES data 
at national level in their analyses, both were 
based on weekly admissions and hence 
involved more robust statistical models.  
 
Furthermore, although the estimated 
smoking ban effect was adjusted for changes 
in cigarette smoking prevalence, the 
reported level was still liable to bias from 
residual confounding. The likely impact 
would be that reductions in admissions due 
to decrease in active smoking levels might 
have been attributed to the ban. Another 
source of possible bias was the non-
adjustment of the smoking ban effect by a 
number of important factors related to 
COPD, such as comorbidity, changes in the 
management of COPD and other known risk 
factors of COPD.  
 
Indeed, an additional limitation of the study 
was the change in COPD diagnosis which 
occurred over the period of the study. While 
in 2001, according to GOLD 2001, chronic 
bronchitis was classified as stage 0 (i.e. at 
risk of COPD), this stage was deleted in 
2006 when bronchitis chronic was classified 
as a different disease from COPD. 
 
These are problems commonly associated 
with ecological studies and as such, the 
reported results require caution in their 
interpretation and any conclusions on 
possible causality.  
 
Strengths  
 
Ecological studies can provide evidence for 
identifying associations at the population 
level and as reported by Rose (1985), they 
are generally suitable for evaluating the 
effect of public health policy which would 
otherwise be very difficult to conduct.  This 
study used freely available HES data to 
assess whether there was evidence of 
reductions in annual emergency admissions 
for COPD as a result of the implementation 
of the smoke-free legislation in England in 
2007. It is the first study to assess the 
impact of the smoking ban on COPD.  
 
Conclusions  
 
The results of our study suggest emergency 
admissions for COPD declined significantly 
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in men, but not in women, following the 
implementation of smoke-free legislation in 
England. This reduction of emergency 
admissions comes on top of those reported 
for other outcomes such as myocardial 
infarction and asthma, thereby further 
shifting its cost-benefit ratio further in favor 
of the implementation of the intervention.  
Because these trends were observed at an 
ecological level, the findings should be 
considered as indicative only and further 
investigation, using individual-level data, 
would be needed to more accurately 
estimate the impact of the introduction of 
the smoking ban in terms of the huge cost 
and quality of life implications of the 
thousands of emergency admission for 
COPD in the UK.  
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